Evidence map›Paper›PMID 36566913›Full record

ArticleClinical immunology (Orlando, Fla.)2023

Kidney tubular epithelial cell ferroptosis links glomerular injury to tubulointerstitial pathology in lupus nephritis.

Abdel A Alli, Dhruv Desai, Ahmed Elshika, Marcus Conrad, Bettina Proneth, William Clapp, Carl Atkinson, Mark Segal, Louis A Searcy, Nancy D Denslow and 4 more

Open access · greenAbstract read
In one paragraph

Article in Clinical immunology (Orlando, Fla.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 71 citations in OpenAlex.

  1. Review
  2. Ferroptosis in kidney disease.Nature reviews. Nephrology · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. A population-scale atlas of blood and tissue in lupus nephritis.bioRxiv : the preprint server for biology · 2026
    Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Ferroptosis inhibitors: mechanisms of action and therapeutic potential.Cellular and molecular life sciences : CMLS · 2025
    Review
  17. Review
  18. Review
  19. Review
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Abdel A AlliDepartment of Physiology and Aging, University of Florida, Gainesville, USA.
Dhruv DesaiDepartment of Medicine, University of Florida, Gainesville, USA.
Ahmed ElshikaDepartment of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, USA.
Marcus ConradInstitute of Metabolism and Cell Death, Helmholtz Zentrum Munich, Germany.
Bettina PronethInstitute of Metabolism and Cell Death, Helmholtz Zentrum Munich, Germany.
William ClappDepartment of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, USA.
Carl AtkinsonDepartment of Medicine, University of Florida, Gainesville, USA.
Mark SegalDepartment of Medicine, University of Florida, Gainesville, USA.
Louis A SearcyDepartment of Physiological Sciences and Center for Environmental and Human Toxicology, University of Florida, Gainesville, USA.
Nancy D DenslowDepartment of Physiological Sciences and Center for Environmental and Human Toxicology, University of Florida, Gainesville, USA.
Subhashini BolisettyDepartment of Medicine, University of Alabama, Birmingham, USA.
Borna MehradDepartment of Medicine, University of Florida, Gainesville, USA.
Laurence MorelDepartment of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, USA.
Yogesh ScindiaDepartment of Medicine, University of Florida, Gainesville, USA; Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, USA. Electronic address: yogesh.scindia@medicine.ufl.edu.
University of Florida · USHelmholtz Zentrum München · DEUniversity of Alabama at Birmingham · US

Funding

Multiscale modeling of the role of heme during invasive pulmonary aspergillosisR01AI135128 · NIAID · UNIVERSITY OF FLORIDA · PI REINHARD LAUBENBACHER, Borna Mehrad · 2018 to 2026
$4.9M
Modular design of multiscale models, with an application to the innate immune response to fungal respiratory pathogens.U01EB024501 · NIBIB · UNIVERSITY OF FLORIDA · PI LAUBENBACHER, REINHARD, MEHRAD, BORNA · 2017 to 2020
$2.9M
Targeting follicular helper CD4 T cells in SLER01AI128901 · NIAID · UNIVERSITY OF FLORIDA · PI MOREL, LAURENCE · 2017 to 2021
$1.8M
Functional Significance of Ferritin Light Chain in Sepsis-associated Kidney InjuryR01DK122986 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BOLISETTY, SUBHASHINI · 2021 to 2025
$1.7M
Applied Biosystems SCIEX Q-TRAP 6500 LC/MS/MS Mass SpectrometerS10OD018141 · OD · UNIVERSITY OF FLORIDA · PI DENSLOW, NANCY D · 2015 to 2015
$584k
NIAID NIH HHS R01 AI128901NIAID NIH HHS R01 AI135128NIBIB NIH HHS U01 EB024501NIDDK NIH HHS R01 DK122986NIH HHS S10 OD018141
6 · The paper itself

Abstract

Ferroptosis is a druggable, iron-dependent form of cell death that is characterized by lipid peroxidation but has received little attention in lupus nephritis. Kidneys of lupus nephritis patients and mice showed increased lipid peroxidation mainly in the tubular segments and an increase in Acyl-CoA synthetase long-chain family member 4, a pro-ferroptosis enzyme. Nephritic mice had an attenuated expression of SLC7A11, a cystine importer, an impaired glutathione synthesis pathway, and low expression of glutathione peroxidase 4, a ferroptosis inhibitor. Lipidomics of nephritic kidneys confirmed ferroptosis. Using nephrotoxic serum, we induced immune complex glomerulonephritis in congenic mice and demonstrate that impaired iron sequestration within the proximal tubules exacerbates ferroptosis. Lupus nephritis patient serum rendered human proximal tubular cells susceptibility to ferroptosis which was inhibited by Liproxstatin-2, a novel ferroptosis inhibitor. Collectively, our findings identify intra-renal ferroptosis as a pathological feature and contributor to tubular injury in human and murine lupus nephritis.

Indexed as

FerroptosisKidney DiseasesLupus NephritisAnimalsEpithelial CellsHumansIronKidney GlomerulusMiceIronACSL4FerroptosisGPX4IronLiproxstatinLupus nephritisSLE

Identifiers

PMID36566913
PMCPMC10810556
OpenAlexW4312194871

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.